229 related articles for article (PubMed ID: 21139576)
1. Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies.
Rubenstein JH; Scheiman JM; Sadeghi S; Whiteman D; Inadomi JM
Am J Gastroenterol; 2011 Feb; 106(2):254-60. PubMed ID: 21139576
[TBL] [Abstract][Full Text] [Related]
2. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
3. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
[TBL] [Abstract][Full Text] [Related]
6. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
Chandar AK; Keerthy K; Gupta R; Grady WM; Canto MI; Shaheen NJ; Thota PN; Iyer PG; Wang JS; Falk GW; Abrams JA; Dumot J; Faulx A; Markowitz SD; Willis J; Moinova H; Guda K; Brock W; Chak A
Am J Gastroenterol; 2024 May; 119(5):823-829. PubMed ID: 37975600
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of young patients with early Barrett's neoplasia.
Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
[TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus and esophageal adenocarcinoma in adults: long-term GERD or something else?
Pondugula K; Wani S; Sharma P
Curr Gastroenterol Rep; 2007 Dec; 9(6):468-74. PubMed ID: 18377797
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
Runge TM; Abrams JA; Shaheen NJ
Gastroenterol Clin North Am; 2015 Jun; 44(2):203-31. PubMed ID: 26021191
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic Screening Program for Control of Esophageal Adenocarcinoma in Varied Populations: A Comparative Cost-Effectiveness Analysis.
Rubenstein JH; Omidvari AH; Lauren BN; Hazelton WD; Lim F; Tan SX; Kong CY; Lee M; Ali A; Hur C; Inadomi JM; Luebeck G; Lansdorp-Vogelaar I
Gastroenterology; 2022 Jul; 163(1):163-173. PubMed ID: 35364064
[TBL] [Abstract][Full Text] [Related]
11. Gender difference in gastro-esophageal reflux diseases.
Asanuma K; Iijima K; Shimosegawa T
World J Gastroenterol; 2016 Feb; 22(5):1800-10. PubMed ID: 26855539
[TBL] [Abstract][Full Text] [Related]
12. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis.
Kauttu TM; Rantanen TK; Sihvo EI; Räsänen JV; Puolakkainen P; Salo JA
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1450-4; discussion 1454. PubMed ID: 21546258
[TBL] [Abstract][Full Text] [Related]
13. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
Schlottmann F; Molena D; Patti MG
Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
[TBL] [Abstract][Full Text] [Related]
14. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
15. Incidence of GERD, esophagitis, Barrett's esophagus, and esophageal adenocarcinoma after bariatric surgery.
Bevilacqua LA; Obeid NR; Yang J; Zhu C; Altieri MS; Spaniolas K; Pryor AD
Surg Obes Relat Dis; 2020 Nov; 16(11):1828-1836. PubMed ID: 32711954
[TBL] [Abstract][Full Text] [Related]
16. The Race-Specific Incidence of Esophageal Squamous Cell Carcinoma in Individuals With Exposure to Tobacco and Alcohol.
Prabhu A; Obi K; Lieberman D; Rubenstein JH
Am J Gastroenterol; 2016 Dec; 111(12):1718-1725. PubMed ID: 27575710
[TBL] [Abstract][Full Text] [Related]
17. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
18. Editorial: should women with heartburn undergo screening upper endoscopy for prevention of cancer?
Shaheen NJ
Am J Gastroenterol; 2011 Feb; 106(2):261-3. PubMed ID: 21301454
[TBL] [Abstract][Full Text] [Related]
19. Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction.
Rubenstein JH; Raghunathan T; Doan C; Schneider J; Zhao W; Metko V; Nofz K; Khodadost M; Corley DA
Am J Gastroenterol; 2021 May; 116(5):949-957. PubMed ID: 33852454
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case-Control Population in Germany.
Schmidt M; Ankerst DP; Chen Y; Wiethaler M; Slotta-Huspenina J; Becker KF; Horstmann J; Kohlmayer F; Lehmann A; Linkohr B; Strauch K; Schmid RM; Quante AS; Quante M
Cancer Prev Res (Phila); 2020 Apr; 13(4):377-384. PubMed ID: 32066580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]